Study guide
12.3 Immunizations & Preventive Care for Older Adults
ANCC Gerontological Nursing Certification GERO-BC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the GERO-BC Exam 1.2 Eligibility, Fees, Scoring & Testing 1.3 How to Study for GERO-BC
2 Assessment Tools: Physical & Psychosocial
2.1 Fall, Depression & Pressure-Injury Risk Tools 2.2 Cognitive Assessment Tools (MMSE, MoCA, SLUMS, CAM) 2.3 Functional (ADL/IADL) & Pain Assessment
3 Social Determinants & Care Context
3.1 Social Determinants of Health in Aging 3.2 Caregiver & Support-System Assessment 3.3 Living Environment & Access Barriers
4 Pharmacotherapy Assessment
4.1 Polypharmacy Identification & Medication Review 4.2 Drug Interactions in Older Adults 4.3 Pharmacokinetic Changes with Aging
5 Aging Physiology & Clinical Findings
5.1 Sensory & Neurological Aging Changes 5.2 Circulatory & Cardiopulmonary Aging 5.3 Distinguishing Normal Aging from Pathology
6 Risk Factor Identification
6.1 Cognitive Impairment Risk Recognition 6.2 Non-Adherence Risk Factors 6.3 Elder Abuse & Neglect Screening
7 Evidence-Based Interventions
7.1 Evidence-Based Interventions & Expected Outcomes 7.2 Chronic Disease Management in Older Adults 7.3 Delirium Prevention & Dementia Care 7.4 Depression Care & Palliative/Hospice Care
8 Medications, Beers Criteria & Contraindications
8.1 Beers Criteria Essentials 8.2 Dosage & Route Modifications for Older Adults 8.3 Food, Drug & Herbal Contraindications
9 Care Planning & Prioritization
9.1 Nursing Diagnosis & Problem-List Evaluation 9.2 Person-Centered Care Planning 9.3 Outcome Evaluation & Plan Revision
10 Safety & Therapeutic Environment
10.1 Fall Prevention Interventions 10.2 Restraint Alternatives, Infection Control & Skin Integrity 10.3 Therapeutic Environment & Milieu Management 10.4 Wound Care Essentials for Older Adults
11 Care Coordination Across the Continuum
11.1 Transitions of Care 11.2 Case Management & Community Resources 11.3 Caregiver Support Systems
12 Theories, Prevention & Health Promotion
12.1 Theoretical Frameworks in Gerontology 12.2 Disease Prevention & Screenings 12.3 Immunizations & Preventive Care for Older Adults 12.4 Self-Management & Health Promotion Strategies
13 Communication & Adult Learning
13.1 Principles of Adult Learning 13.2 Communication Barriers & Adaptations 13.3 Patient & Family Education
14 Diversity, Ethics & Legal Practice
14.1 DEI & Older-Adult Subpopulations 14.2 Advance Directives & Surrogate Decision-Making 14.3 Ethics, Advocacy & Scope of Practice 14.4 Capacity & Informed Consent
15 Regulation, QI & Technology
15.1 CMS & Regulatory Compliance 15.2 Quality Improvement in Gerontological Settings 15.3 EHR & Documentation Standards 15.4 Telehealth, Remote Monitoring & Hospital-at-Home
12.3 Immunizations & Preventive Care for Older Adults
Key Takeaways Explain This Topic AI
Immunizations are a cornerstone of primary prevention for older adults and a frequent GERO-BC application of III-A-2 disease prevention
Prefer high-dose, adjuvanted, or recombinant influenza vaccines for adults ≥65 when available and indicated
Age-based pneumococcal vaccination now commonly starts at age 50; zoster (RZV) is routinely recommended beginning at age 50 (2-dose series)
RSV vaccine is recommended for all adults ≥75 and for adults 50–74 at increased risk of severe RSV; typically one lifetime dose if previously unvaccinated
COVID-19 vaccination guidance is season/update-specific—older adults and immunocompromised persons remain high-priority groups for updated doses
Last updated: August 2026
Immunizations & Preventive Care for Older Adults
Quick Answer: Immunizations are high-yield primary prevention for GERO-BC. For older adults, prioritize annual influenza (prefer HD-IIV / adjuvanted / recombinant formulations at ≥65 ), pneumococcal vaccination (age-based recommendations now commonly begin at 50 ), recombinant zoster vaccine (RZV) starting at 50 (2 doses), RSV for ≥75 (and high-risk 50–74 ), and updated COVID-19 doses per current ACIP/CDC guidance—especially for adults ≥65 and immunocompromised persons.
This section deepens III-A-2 prevention with the vaccine knowledge gerontological nurses use daily in clinics, long-term care, home health, and hospital discharge planning. Schedules evolve; exam items test principles and priority populations more than memorizing every footnote—but you should know the major age thresholds and preferential products.
Why Vaccines Matter More with Age
Immunosenescence reduces vaccine responses and increases severity of vaccine-preventable disease. Older adults have higher rates of:
- Influenza-related hospitalization and death
- Invasive pneumococcal disease
- Herpes zoster and postherpetic neuralgia
- RSV lower-respiratory disease
- Severe COVID-19 outcomes
Nursing role: identify gaps , counsel , administer or coordinate , document , and reduce missed opportunities during every encounter—including hospitalizations and skilled-nursing stays.
Core Adult Vaccines for Aging Populations
Vaccine Typical older-adult recommendation pattern High-yield nursing points
Influenza 1 dose every year ; for ≥65 , prefer high-dose (HD-IIV3) , adjuvanted (aIIV3) , or recombinant (RIV3) when available Do not delay for mild illness; LAIV not for older adults; cocooning of caregivers helps
COVID-19 Updated seasonal formulation per ACIP/CDC; adults ≥65 often recommended additional/updated dosing relative to younger healthy adults Guidance changes by season—emphasize older age and immunocompromise as priority
RSV All adults ≥75 : 1 dose if unvaccinated; ages 50–74 : 1 dose if increased risk of severe RSV Usually no additional doses if previously vaccinated; best timed before RSV season when possible
Pneumococcal Age-based recommendation lowered to begin at 50 (PCV options such as PCV15/PCV20/PCV21 ± PPSV23 depending on product/history) Always review prior PCV/PPSV23 history before choosing series; avoid unnecessary duplicate conjugate doses
Zoster (RZV / Shingrix) 2 doses for adults ≥50 ; also for immunocompromised adults ≥19 per indication Even if prior shingles or older live zoster vaccine; space doses per label (~2–6 months)
Td / Tdap Tdap once if never received as adult, then Td or Tdap booster every 10 years Wound management may need earlier dosing; pregnancy rules differ (not typical GERO focus)
Risk-based vaccines still relevant in late life
Vaccine When gerontological nurses think of it
Hepatitis B Diabetes, dialysis, certain occupational/lifestyle risks; catch-up if never vaccinated and indication present
Hepatitis A Travel, chronic liver disease, other risk groups
MMR / Varicella Usually not routine for older adults born before immunity cutoffs; consider for susceptible health-care personnel per notes
Preferential Influenza Products at Age ≥65
Standard-dose egg-based vaccines are not first choice when preferential products are available. Teach patients that “any flu shot is better than none,” but preferential products improve immune response in older adults:
- High-dose inactivated influenza vaccine
- Adjuvanted inactivated influenza vaccine
- Recombinant influenza vaccine
If preferential products are unavailable, give a standard age-appropriate inactivated or recombinant vaccine rather than skip vaccination.
Pneumococcal Strategy—History First
Pneumococcal schedules are product-history dependent. Safe nursing practice:
Obtain records (EHR, registry, pharmacy, patient card).
Identify whether the person already received PCV13/15/20/21 and/or PPSV23.
Follow current ACIP pathway for age ≥50 or risk-based younger adults.
Counsel that the goal is protection against invasive disease and pneumonia—not “one shot forever” mythology if the series is incomplete.
Missed-opportunity pattern on exams: discharging an unvaccinated 70-year-old after pneumonia without addressing pneumococcal and influenza status.
RSV and COVID-19—Priority Framing
RSV: Think age ≥75 universal (if unvaccinated) and 50–74 with risk conditions (cardiopulmonary disease, immunocompromise, long-term care residence, and other ACIP-listed risks). Timing ideally before local RSV season (often late summer–early fall), but do not refuse an indicated dose solely because season has started if the person remains unvaccinated and eligible.
COVID-19: Schedules have shifted across seasons (universal vs shared decision-making nuances, extra doses for ≥65 and immunocompromised). For GERO-BC reasoning: older age and immunocompromise increase benefit ; keep current with facility/public-health standing orders; document informed discussion when recommendations are individualized.
Contraindications, Precautions, and Counseling
Situation Approach
Anaphylaxis to a prior dose or vaccine component Do not repeat that vaccine; refer to allergy specialist as needed
Moderate/severe acute illness with or without fever Often defer until improved; mild illness is usually OK
Guillain–Barré history timing concerns Individualize per ACIP footnotes; not an automatic lifelong ban for all vaccines
Live vaccines Generally avoided in severe immunocompromise; older-adult influenza uses inactivated/recombinant options
Fear of side effects Expect local arm pain (especially RZV); prep with analgesia plan and schedule around important events
Use motivational interviewing : acknowledge concerns, share age-specific risk of disease, and offer same-day vaccination when possible.
Preventive Care Beyond the Needle
Immunizations sit inside a broader preventive visit:
- Medication review (prevent iatrogenic disease)
- Fall risk and exercise referral
- Vision/hearing checks affecting safety
- Dental/oral health impacting nutrition and aspiration risk
Advance-care planning while the older adult is stable (prevents crisis discord—not a vaccine, but preventive systems care)
- Skin cancer vigilance and sun safety education
- Tobacco and alcohol counseling
- Setting Closing the gap
- Primary care / geriatrics clinic Standing orders; registry outreach
- Hospital Offer indicated vaccines before discharge when stable
- Long-term care Facility programs for influenza/COVID/pneumococcal/RSV per policy and ACIP
- Home health Coordinate pharmacy/clinic administration; educate caregivers
- Documentation Essentials
Record vaccine name, dose, site/route, lot/expiry when required, VIS date, and patient response. Update the immunization information system when applicable. Clear documentation prevents duplicate dosing and supports quality measures tied to older-adult immunization rates.
Immunization excellence on GERO-BC looks like proactive gap closure + age-appropriate product choice + respectful counseling —not waiting for the older adult to ask.